Phesi launches Investigator Site Profile solution, enabling sponsors to eliminate non-active, non-enrolling trial sites
Phesi, a leading clinical development analytics company, has launched a self-service Investigator Site Profile solution designed to eliminate the non-active and non-enrolling investigator sites that development programs are typically burdened with. Investigator Site Profile leverages data from Phesi’s award-winning AI-powered Trial Accelerator™ platform, including records from 600,000 investigator sites in 195 countries. Users of the […]
CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review
CluePoints continues to transform clinical trial review and leverage its industry-leading software to enhance the interrogation, analysis and presentation of data with the launch of its latest application, Medical & Safety Review (MSR). The tool simplifies and streamlines the medical analysis of study data through user-friendly dashboards, data manipulation and cleaning, query management and full transparency over the […]
Phastar Announced as 2024 Scrip Award Finalist for Best Contract Research Organization – Specialist Provider
Phastar, global specialist biometrics contract research organization (CRO), has been named as a finalist for the Best Contract Research Organization – Specialist Providers category at the 2024 Scrip Awards. Phastar was recognized for its Clinical Intelligence Portal, a high-quality data analytics, visualization, and advanced Recruitment Forecasting app, as well as its continued commitment to lead the […]
Bormioli Pharma presents its wide primary pharma packaging offer at CPHI Milan 2024, enabling sustainability and high-quality solutions for the pharma industry
Bormioli Pharma, an international leader in pharmaceutical packaging and medical devices, will be present at CPHI Milan (Fiera Milano, booth 20A2) from October 8th to 10th. The company will showcase its comprehensive range of plastic and glass containers for the pharmaceutical industry, along with caps, closures, and accessories. As part of its commercial offerings, Bormioli Pharma […]
Biotech Capital on the Rise and Outsourcing to Accelerate in 2025 – but Uneven Growth for CDMOs
European Biotech Recovery Gains Momentum as Chinese Biotech Declines, and IPO Activity Remains Weak New research launched at CPHI Milan – the world’s largest pharma event, held at Fiera Milano (October 08-10, 2024) – forecasts promising growth for biotech and pharma markets in the coming year, bringing growth opportunities for outsourcing providers. The event arrives […]
CPHI Milan Report: CMOs and hybrid companies will hold 54% of biologics capacity in 2028
CMOs will account for four of the five biggest capacity holders in 2028, with 45% of all CMO capacity in Asia The world’s largest pharma event, CPHI Milan, is set to open at Fiera Milano from October 8- 10, 2024, with 62,000 executives expected to attend, as the CPHI Annual Report predicts that CMOs and […]
iNova Pharmaceuticals launches iPITCH 2024 – a global crowdsourcing initiative
iNova Pharmaceuticals, in partnership with CoVentured, is thrilled to launch ‘iPitch 2024’, a global crowdsourcing initiative which aims to discover the latest, science-backed innovations in the field of ‘wound care’. iPitch offers product and packaging developers, innovators, research and development labs, licensors and certified manufacturers the opportunity to connect with iNova and showcase innovative consumer […]
OneSource, the Group’s Spec Pharm CDMO, receives equity commitments of INR 8,010 mn (USD 95 mn) from marquee investors at a pre-money equity valuation of USD 1.65 bn
Delivering Strides’ shareholders an embedded value of INR 663 per share for Strides’ holding in OneSource, representing a ~82% premium over the previous embedded value of INR 364 per share as per the Scheme of Arrangement announced earlier in September’23. The fundraise is being led by HBM Healthcare Investments and associated investors, with the additional […]
Uncovering the Truth About Breast Cancer Risk Factors
Breast cancer remains one of the most prevalent cancers among women globally, affecting millions and reshaping lives. The key to combating this disease lies not only in effective treatments but also in a comprehensive understanding of its risk factors. By diving into the various elements that contribute to breast cancer risk, we can empower ourselves […]
Enhancing patient outcomes through a robust data infrastructure strategy
Every step of the biopharmaceutical process generates data — from development to manufacture to distribution. Capturing and centralizing that data can help the industry create and deliver medicines and treatments more quickly and efficiently, ultimately improving patient care and outcomes. However, many biopharma companies still grapple with outdated data management practices, characterized by disconnected data […]
